
All News


FDA has approved cabozantinib (Cometriq, Exelixis and AstraZeneca) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).

Screening practices for multidrug-resistant (MDROs) in intensive care units (ICUs) vary widely from hospital to hospital, according to a new study.

Instead of thinking of the future as something to come, pharmacists should act like the future is here today.

Women who regularly took the analgesics ibuprofen or acetaminophen 2 or more days per week had an increased risk of hearing loss, according to a study.

You might know about medical foods, but they are making their way into ambulatory care and community pharmacy.

A round-up of OTC products that helps get the digestive track back in working order.

After dealing with a patient who was clearly a marijuana user, a pharmacist reflects on how so much attention is paid to illicit drugs, but very little is given to prescription drug abuse.

Individuals with high cholesterol who stay on their statin medications over a two-year period are healthier than comparable nonadherent individuals, but the overall cost of their care is slightly higher, according to a new study.

Patients with nonvalvular atrial fibrillation (NAVF) who also have diabetes experienced similar safety and efficacy with dabigatran relative to warfarin, in comparison without diabetes who have NVAF.

The Affordable Care Act may allow you to make money by filling in the gaps that you already do.

A look at how pharmacists can be involved with the "meaningful use" incentive program.

The Hennepin County Medical Center (HCMC), based in Minneapolis, Minn., significantly reduced hospital readmissions and emergency room visits by forming an accountable care organization (ACO) team.

A pharmacist looks at the life expectancy numbers in the U.S. and wonders how healthcare could have come so far, but still be failing patients.

Has the pharmacy grind made you dream of owning your own? It's not as simple as you might think.

A new study indicates that adults are keeping their hypertension in check.

A survey of new Rx, new generic, and new OTC products

After attending a high school reunion, a pharmacist reflects on what he'd learn through a reunion of his pharmacy career.

The first in a series of articles on the work that social media can do for pharmacists,

Readers discuss taking the time to research, the need for care when purchasing drugs, the need to be more visible to the public, and arguing that cyberconsulting is too dangerous to practice in.

A look at the meningitis outbreak that killed 36 and whether or not legislation could prevent a similar tragedy from occurring.

The fungal meningitis outbreak can serve as a reminder of the need for risk management.

Two pharmacy students argue that the push needs to continue for attaining provider status and it's important to include students.

Almost $1.8 million was raised for research and educational initiatives at the National Association of Chain Drug Stores Foundation dinner Nov. 27.

Physicians Interactive and McKesson Patient Relationship Solutions are launching an automated pharmaceutical voucher and coupon distribution solution called eCoupon, according to press release.

The U.S. Preventive Services Task Force (USPSTF) is seeking public comment on its draft recommendation on adult screening for hepatitis C virus (HCV) until Dec. 24, the agency announced.

Pesticides used incorrectly to treat infestations of beg bugs and other insects indoors can be harmful to humans, according to a health advisory from the Centers for Disease Control and Prevention (CDC).

The Drug Enforcement Administration (DEA) issued a notice to three Walgreens pharmacies in Florida on Nov. 27, asking them to show why the DEA should not revoke their DEA registrations.

More than 40 lots of atorvastatin calcium tablets, the generic version of Pfizer?s Lipitor, are being recalled by Ranbaxy Pharmaceuticals Inc. (RPI) because they may contain glass particles that are estimated to be less than 1 mm in size, according to Ranbaxy's website.

An FDA advisory panel voted against making oxybutynin transdermal patch (Oxytrol, Merck and Watson Pharma) available over-the-counter (OTC) for overactive bladder (OAB) in women, Medpage Today reported.